ETHYL (S)-10-FLUORO-3-METHYL-9-(4-METHYLPIPERAZIN-1-YL)-7-OXO-2,3-DIHYDRO-7H-(1,4)OXAZINO(2,3,4-IJ)QUINOLINE-6-CARBOXYLATE
UNII V7HP5A9J8N
Substance Identification & Data
This profile provides standardized clinical and technical data for Ethyl (s)-10-fluoro-3-methyl-9-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7h-(1,4)oxazino(2,3,4-ij)quinoline-6-carboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) V7HP5A9J8N.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2130840-92-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C20H24FN3O4 MOTRHZBQXJOHCK-LBPRGKRZSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Ethyl (s)-10-fluoro-3-methyl-9-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7h-(1,4)oxazino(2,3,4-ij)quinoline-6-carboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.